GMV The Future, page-1282

FCL needed to provide samples of Packaging, instructions, guidelines etc to FDA, so pretty straight forward stuff at this stage.

Still stand by my comment the factory has already been producing. Remember the discrepancy between sales and inventory recently? Reason they had no sales was because they are being loaned out for recurring revenue to the doctors in the US. Sales team has increased and doing the rounds but this is my opinion only.

Yacov stated while here they need to source more components. They will also have stock in the factory ready to go for Taiwan is my opinion. The question becomes in this changing world environment, will they sell them outright at first or loan them out in Taiwan, until they can mass produce?